Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: A pilot study

  1. Álvarez, C.
  2. Alonso-Muriel, I.
  3. García, G.
  4. Crespo, J.
  5. Bellver, J.
  6. Simón, C.
  7. Pellicer, A.
Aldizkaria:
Human Reproduction

ISSN: 1460-2350,  0268-1161

Argitalpen urtea: 2007

Alea: 22

Zenbakia: 12

Orrialdeak: 3210-3214

Mota: Artikulua

DOI: 10.1093/HUMREP/DEM315 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus